US Patent 7566803 Vitamin D receptor modulators
Patent 7566803 was granted and assigned to Eli Lilly and Company on July, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Jianliang Lu0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+269 characters)
Article
Patent abstract
The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07566803 Vitamin D receptor modulators US Patent 7566803 Vitamin D receptor modulators
Infobox
Patent Number
07566803
Patent Number
7566803
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07566803 Vitamin D receptor modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07566803
Date of patent
July 28, 2009
Patent application number
10534920
Date Filed
November 20, 2003
Patent primary examiner
Find more entities like US Patent 7566803 Vitamin D receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
